Square (NYSE: SQ) fell 18.1% in November, according to data from S&P Global Market Intelligence, because of disappointing quarterly results and declining Bitcoin market prices. Investors weren't impressed by Square's revenue growth, and the company's increasing exposure to cryptocurrencies also weighed on the stock, as Bitcoin (CRYPTO: BTC) had a volatile month. Square's quarterly revenue growth slowed dramatically and fell short of analyst estimates. Read More...
Motley Fool
Why Shares of Pfizer, Ocugen, and Vaxart Are Losing Ground Today
Shares of the COVID-19 vaccine makers Pfizer (NYSE: PFE), Ocugen (NASDAQ: OCGN), and Vaxart (NASDAQ: VXRT) are all moving in the wrong direction today. Specifically, Pfizer’s stock is down by approximately 4%, Ocugen’s equity is in the red by 5.64%, and Vaxart’s shares are underwater by a hefty 8.7%, as of 12:23 p.m. ET Monday afternoon. On Sunday, the White House’s chief medical advisor, Dr. Anthony Fauci, said that the preliminary data regarding the severity of the omicron variant was “encouraging.”
Add Comment